期刊文献+

可磷酸化短肽偶联壳聚糖促进CS/DNA转染效率 被引量:3

Phosphorylatable Short Peptide Coupled Chitosan Facilitates Transfection Efficiency of the CS /DNA Complex
下载PDF
导出
摘要 合成基序为LLLRRRDNEY*FY*VRRLL的短肽(pSP),其中含有两个可被JaK2蛋白激酶磷酸化的酪氨酸残基.将此短肽与壳聚糖(CS)相偶联,体外磷酸化及DNA释放实验检测哺乳动物细胞裂解液对短肽的磷酸化及pSP-CS/DNA复合物中DNA释放的影响.放射性标记DNA转移实验验证pSP-CS/DNA复合物的入胞能力后,将荷荧光素酶或GFP报告基因的质粒与pSP-CS制成pSP-CS/DNA复合物,转染体外培养的C2C12小鼠成肌细胞,观察GFP的分布及细胞裂解液中的荧光素酶活性以表征转染效率.继而进行多种细胞系的转染,衡量pSP偶联的壳聚糖对不同种属细胞的转染效率.结果表明,哺乳动物细胞裂解液可有效地使短肽发生磷酸化,并藉此促进DNA与壳聚糖载体的解离.以pSP修饰的壳聚糖进行转染时,细胞裂解液的荧光素酶活性可达普通壳聚糖转染的两倍,细胞中GFP的含量也明显增加.据此推论,短肽被磷酸化后产生电荷属性的改变,促进DNA与壳聚糖载体的解离从而显著提高壳聚糖的转染效率. We have previously demonstrated that the degradation of chitosan promoted by the enhanced intracellular unpacking of the exogene from chitosan carrier could markedly improve the transfection efficiency of CS /DNA complex. Here we tested whether chitosan modification by phosphorylatable short peptide facilitated the intracellular DNA unpacking to further enhance CS /DNA transfection. A synthesized phosphorylatable short peptide ( pSP) with the sequence of LLLRRRDNEY FY VRRLL contained two potential phosphorylatable tyrosine residues by constitutively expressed cytoplasmic protein kinase Jak2. The pSP-CS /DNA complex was prepared using a GFP or Luciferase reporter plasmid and chitosan conjugated to pSP. In vitro phosphorylation and DNA releasing assays showed that mammalian cell lysate phosphorylated SP effectively and promoted the DNA unpacking from the carrier. High cell membrane permeability of the pSP-CS /DNA complex was observed by 32P labeled plasmid transforming assays. C2C12 myoblast cells were transfected with pSP-CS /DNA of the GFP or luciferase plasmid and the transfection efficiency determined by the expression levels of the reporter genes. Various cell lines were transfected by the complex with a Luciferase reporter and the results showed that the transfection efficiency was near to that of lipofectamine 2000.
出处 《中国生物化学与分子生物学报》 CAS CSCD 北大核心 2010年第8期734-739,共6页 Chinese Journal of Biochemistry and Molecular Biology
基金 国家自然科学基金资助项目(No30600146) 天津市自然科学基金重点项目(No06YFJZJC00800)~~
关键词 短肽 磷酸化 壳聚糖 解离 转染效率 short peptide(SP) phosphorylation chitosan(CS) dissociation transfection efficiency
  • 相关文献

参考文献17

  • 1Lebedeva I, Beimetskaya L, Stein C A, et al. Cellular delivery of antisense oligonucleotides[ J]. Eur J Pharm Biopharm,2000, 50(1): 101-119.
  • 2Garcia-Chaumont C G, Seksek O, Grzybowska J, et al. Delivery systems for antisense oligonucleotldes [J].Pharmacol Ther, 2000,87 ( 2-3 ) : 255 -277.
  • 3Kataoka K, Harashima H. Gene delivery systems: viral vs nonviral vectors[J]. Adv Drug Deliv Rev, 2001, 52:151.
  • 4Wang I I, Huang I I. Adenovirus technology for gene manipulation and functional studies [ J ]. Drug Discov Today, 2000,5(1) : 10-16.
  • 5Luo D,Salzman W M. Synthetic DNA delivery systems[ J]. Nat Biotechnol,2000,18( 1 ) : 33-37.
  • 6Wang J, Tao X, Zhang Y, et al. Reversion of multidrug resistance by tumor targeted delivery of antisense oligodeoxynucleotides in hydroxypropyl-chitosan nanoparticles [J]. Biomaterials, 2010,31(15) :4426-4633.
  • 7Kievit FM, Veiseh O, Bhattarai N, et al. PEI-PEG-chitosan copolymer coated iron oxide nanoparticles for safe gene delivery: synthesis, complexation, and transfection[ J]. Adv Funct Mater, 2009,19 (14) :2244-2251.
  • 8Brokx R, Gariepy J. Peptide and polymer-based gene delivery vehicles[ J]. Methods Mol Med,2004, 90 : 139-160.
  • 9郑爱萍,王奎书,郝睿,李明光,王坚成,张强.胸腺五肽pH-敏感壳聚糖纳米粒的制备、体外释放及生物活性[J].中国药学杂志,2007,42(9):679-685. 被引量:11
  • 10Moon I J, Kang H, Seu Y B, et al. Marked transfection enhancement by the DPL (DNA/peptide/lipid) complex[ J]. Int J Mol Med, 2007, 20(4) : 429-437.

二级参考文献7

  • 1GONSER S,WEBER E,FOLKERS G.Peptides and polypeptides as modulators of the immune response:thymopentin an example with unknown mode of action[ J].Pharma Acta Helve,1999,73(6):265-273.
  • 2CONTIN B,PANICO M,VENTURA C A,et al.Thymopentin loaded micro sphere preparation by w/o/w emulsion technique:in vitro/ex vivo evaluation[ J ].J Microencap,1997,14:303-310.
  • 3AKTAS Y,ANDRIEUX K,ALONSO M J,et al.Preparation and in vitro evaluation of chitosan nanoparticles containing a caspase inhibitor[ J].Int J Pharm,2005,298:378-383.
  • 4KNAUL J Z,HUDSON S M,CREBER K A M.Improved mechanical properties of chitosan fibers[ J ].J Appl Polym Sci,1999,72:1721-1731.
  • 5AGNIHOTRI S,MALLIKARJUNA N,AMINABHAVI T.Recent advances on chitosan-based micro-and nanoparticles in drug delivery[J].J Controlled Release,2004,100(1):5-28.
  • 6蒋定文,李楚芳.胸腺五肽研究进展[J].国外医学(预防.诊断.治疗用生物制品分册),1999,22(2):69-72. 被引量:20
  • 7何伟玲,张志荣,蒋学华,聂宇,吴芳.制剂工艺条件下的胸腺五肽稳定性评价[J].四川大学学报(医学版),2003,34(2):292-294. 被引量:10

共引文献10

同被引文献48

  • 1Opanasopit P, Tragulpakseerojn J, Apirakaramwong A, et al. Chitosan enhances transfection efficiency of cationic polypeptides/DNA complexes[J]. Int J Pharm, 2011, 410 ( 1- 2) :161-168.
  • 2Wang B, He C, Tang C, et al. Effects of hydrophobic and hydrophilic modifications on gene delivery of amphiphilic chitosan based nanocarriers [ J]. Biomaterials, 2011, 32 (20) :4630-4638.
  • 3Varkouhi A K, Verheul R J, Schiffelers R M, et al. Gene silencing activity of siRNA polyplexes based on thiolated N, N, N- trimethylated chitosan [ J ]. Bioconjug Chem, 2010, 21 ( 12 ) : 2339-2346.
  • 4Liao Z X, Ho Y C, Chen H L, et al. Enhancement of efficiencies of the cellular uptake and gene silencing of chitosan/ siRNA complexes via the inclusion of a negatively charged poly ( γ-glutamic acid ) [ J]. Biomaterials ,2010,31 ( 33 ) :8780-8788.
  • 5Rudzinski W E, Aminabhavi T M. Chitosan as a carrier for targeted delivery of small interfering RNA [ J ]. Int J Pharm, 2010, 399(1-2) :1-11.
  • 6Mao S, Sun W, Kissel T. Chitosan-based formulations for delivery of DNA and siRNA[J]. Adv Drug Deliv Rev,2010, 62 (1) :12-27.
  • 7Wang J, Tao X, Zhang Y, et al. Reversion of multidrug resistance by tumor targeted delivery of antisense oligodeoxynucleotides in hydroxypropyl-chitosan nanoparticles [ J]. Biomaterials,2010, 31 ( 15 ) : 4426-4433.
  • 8Bramsen J B, Kjems J. Chemical modification of small interfering RNA [ J]. Methods Mol Biol, 2011, 721 : 77-103.
  • 9Wang J, Lu Z, Wientjes M G, et al. Delivery of siRNA therapeutics: barriers and carriers[J]. AAPS J, 2010, 12(4) : 492 -503.
  • 10Deleavey G F, Watts J K, Alain T, et al. Synergistic effects between analogs of DNA and RNA improve the potency of siRNA-mediated gene silencing [ J ]. Nucleic Acids Res, 2010, 38 ( 13 ) :4547-4557.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部